Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

被引：33

作者：

Kosmider, Olivier ^{[1
]}

Passet, Marie ^{[1
]}

Santini, Valeria ^{[2
]}

Platzbecker, Uwe ^{[3
]}

Andrieu, Valerie ^{[4
]}

Zini, Gina ^{[5
]}

Beyne-Rauzy, Odile ^{[6
]}

Guerci, Agnes ^{[7
]}

Masala, Erico ^{[8
]}

Balleari, Enrico ^{[9
]}

Bulycheva, Ekaterina ^{[3
]}

Dreyfus, Francois ^{[10
]}

Fenaux, Pierre ^{[11
]}

Fontenay, Michaela ^{[1
]}

Park, Sophie ^{[12
]}

机构：

[1] Hop Cochin, AP HP, Hematol Biol, Paris, France

[2] Univ Florence, AOU Careggi, Hematol, I-50121 Florence, Italy

[3] Univ Hosp Carl Gustav Dresden, Dresden, Germany

[4] Hop Bichat Claude Bernard, AP HP, Hematol Biol, Paris, France

[5] Univ Cattolica Sacro Cuore, Rome, Italy

[6] Oncopole, IUCT, Toulouse, France

[7] Hop Brabois, Nancy, France

[8] Univ Florence, Florence, Italy

[9] IRCCS AOU San Martino IST Genova, Genoa, Italy

[10] Hop Cochin, Serv Hematol, Paris, France

[11] Hop St Louis, Serv Hematol Seniors, Paris, France

[12] Univ Grenoble Alpes, CHU Grenoble Alpes, Clin Univ Hematol, Grenoble, France

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 07期

关键词：

myelodysplastic syndromes; cytogenetics and molecular genetics; red cells; SURVIVAL; IMPACT; MODEL;

D O I：

10.3324/haematol.2016.142695

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：280 / 283

页数：4

共 50 条

[11] Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
Erica Tsang
Heather A. Leitch
Annals of Hematology, 2016, 95 : 73 - 78
[12] Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?
Tsang, Erica
Leitch, Heather A.
ANNALS OF HEMATOLOGY, 2016, 95 (01) : 73 - 78
[13] COMMITTED AND IMMATURE ERYTHROID PROGENITORS ARE DIFFERENTLY DISTRIBUTED IN LOWER RISK MYELODYSPLASTIC SYNDROMES ACCORDING TO WHO CATEGORY AND CORRELATE WITH RESPONSE TO ERYTHROPOIESIS STIMULATING AGENTS
Raddi, M. G.
Consagra, A.
Rigodanza, L.
Amato, C.
Tofacchi, E.
Cassari, M.
De Pourcq, S.
Mattiuz, G.
Bencini, S.
Peruzzi, B.
Sanna, A.
Annunziato, F.
Fontenay, M.
Chapuis, N.
Santini, V.
LEUKEMIA RESEARCH, 2023, 128
[14] Efficacy of granulocyte colony stimulating factor in combination with erythropoiesis stimulating agents for treatment of anemia in patients with lower risk myelodysplastic syndromes: A systematic review
Affentranger, Lucas
Bohlius, Julia
Hallal, Mahmoud
Bonadies, Nicolas
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 136 : 37 - 47
[15] SUPPORTIVE CARE IN LOW-RISK MYELODYSPLASTIC SYNDROMES: ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS)
Cerchione, C.
Alfinito, F.
Soriente, I.
D'Arco, A. M.
Danise, P.
Cerciello, G.
Musuraca, G.
Lucchesi, A.
Di Battista, V.
Cangini, D.
Giannini, M. B.
Ronconi, S.
Ceccolini, M.
Pane, F.
Martinelli, G.
HAEMATOLOGICA, 2022, 107 : 65 - 66
[16] ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES
Cerchione, C.
Martinelli, G.
Soriente, I.
D'Arco, A. M.
Danise, P.
Cerciello, G.
Di Battista, V.
Cangini, D.
Giannini, M. B.
Pane, F.
Alfinito, F.
HAEMATOLOGICA, 2019, 104 : 147 - 148
[17] Supportive Care in Low-Risk Myelodysplastic Syndromes: Role of Erythropoiesis Stimulating Agents (ESAs)
Cerchione, Claudio
Alfinito, Fiorella
Giannini, Benedetta Maria
Pane, Fabrizio
Musuraca, Gerardo
Martinelli, Giovanni
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S318 - S318
[18] ROLE OF ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN SUPPORTIVE CARE OF LOW-RISK MYELODYSPLASTIC SYNDROMES
Cerchione, C.
Alfinito, F.
Soriente, I.
D'Arco, A. M.
Danise, P.
Cerciello, G.
Musuraca, G.
Lucchesi, A.
Di Battista, V.
Cangini, D.
Giannini, M. B.
Ronconi, S.
Ceccolini, M.
Pane, F.
Martinelli, G.
HAEMATOLOGICA, 2020, 105 : S76 - S76
[19] Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study
Garelius, Hege Kristin Gravdahl
Bagguley, Timothy
Taylor, Adele
Fenaux, Pierre
Bowen, David
Symeonidis, Argiris
Mittelmann, Moshe
Stauder, Reinhard
Cermak, Jaroslav
Sanz, Guillermo
Langemeijer, Saskia
Malcovati, Luca
Germing, Ulrich
Sanhes, Laurence
d'Aveni, Maud
Culligan, Dominic
Kotsianidis, Ioannis
Koinig, Karin A.
van Marrewijk, Corine
Crouch, Simon
Dewitte, Theo
Smith, Alexandra
Hellstroem-Lindberg, Eva
LANCET HAEMATOLOGY, 2025, 12 (02): : e128 - e137
[20] PRE AND POST-TREATMENT SERUM FERRITIN LEVELS IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES RECEIVING ERYTHROPOIESIS STIMULATING AGENTS
Tsang, E.
Leitch, H. A.
HAEMATOLOGICA, 2014, 99 : 89 - 89

← 1 2 3 4 5 →